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Cellular oxido-reductive proteins of
Chlamydomonas reinhardtii control the
biosynthesis of silver nanoparticles
Indu Barwal1, Peeyush Ranjan2, Suneel Kateriya2 and Subhash Chandra Yadav1*
Abstract
Background: Elucidation of molecular mechanism of silver nanoparticles (SNPs) biosynthesis is important to
control its size, shape and monodispersity. The evaluation of molecular mechanism of biosynthesis of SNPs is of
prime importance for the commercialization and methodology development for controlling the shape and size
(uniform distribution) of SNPs. The unicellular algae Chlamydomonas reinhardtii was exploited as a model system to
elucidate the role of cellular proteins in SNPs biosynthesis.
Results: The C. reinhardtii cell free extract (in vitro) and in vivo cells mediated synthesis of silver nanoparticles
reveals SNPs of size range 5 ± 1 to 15 ± 2 nm and 5 ± 1 to 35 ± 5 nm respectively. In vivo biosynthesized SNPs
were localized in the peripheral cytoplasm and at one side of flagella root, the site of pathway of ATP transport
and its synthesis related enzymes. This provides an evidence for the involvement of oxidoreductive proteins in
biosynthesis and stabilization of SNPs. Alteration in size distribution and decrease of synthesis rate of SNPs in
protein-depleted fractions confirmed the involvement of cellular proteins in SNPs biosynthesis. Spectroscopic and
SDS-PAGE analysis indicate the association of various proteins on C. reinhardtii mediated in vivo and in vitro
biosynthesized SNPs. We have identified various cellular proteins associated with biosynthesized (in vivo and in
vitro) SNPs by using MALDI-MS-MS, like ATP synthase, superoxide dismutase, carbonic anhydrase, ferredoxin-NADP+
reductase, histone etc. However, these proteins were not associated on the incubation of pre-synthesized silver
nanoparticles in vitro.
Conclusion: Present study provides the indication of involvement of molecular machinery and various cellular
proteins in the biosynthesis of silver nanoparticles. In this report, the study is mainly focused towards
understanding the role of diverse cellular protein in the synthesis and capping of silver nanoparticles using C.
reinhardtii as a model system.
Background
Silver nanoparticles (SNPs) have extensive applications
in civil, therapeutic and industrial areas as catalyst, cryo-
genic superconductor, biosensor, microelectronic and
bacteriostatic materials [1-3], etc. These SNPs have been
synthesized by various physical, chemical and biological
methods. Among the various known synthesis methods,
biosynthesis of silver nanoparticles is preferred as it is
environmentally safe, low cost and less toxic [4]. These
biologically synthesized silver nanoparticles (SNPs)
could have better applications in therapeutics, drug
delivery, anticancer and bio-imaging techniques. It has
been known for the long time that in nature a variety of
nanomaterials were synthesized by biological machinery.
For example, the magneto-tactic bacteria synthesize
intracellular magnetite nanocrystallites [5], diatoms
synthesize siliceous materials [6], S-layer bacteria pro-
duce gypsum/calcium carbonate layers [7] and plants
(algae, fungi, gymnosperms and angiosperms) for gold
and silver nanoparticles [8]. In the past few years, bio-
production of size and shape controlled SNPs has
become a new and interesting research focus of the field
[9-11]. The size and shape control of biosynthesized
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SNPs could be achieved by appreciative workout of bio-
molecular and biochemical mechanism of SNPs bio-
synthesis. However, the biosynthesis mechanism of these
silver nanoparticles by bio-molecular reduction and sta-
bilization are still elusive. Some reports have highlighted
the mechanism of metallic nanoparticles biosynthesis
from different biological extract in vitro[12-14]. The
overall biosynthesis of silver nanoparticles is reported as
two-step reaction [8]. The first step involves trapping of
Ag+ inside the cell cytoplasm. In the second step,
enzymes present in the cells are responsible for the
reduction of silver ions. However, these investigators
had not delineated the molecular machinery and invol-
vement of biomolecules for SNPs biosynthesis. In
another report, the presence of hydrogenase in the F.
oxysporum broth was assumed to be responsible for the
biosynthesis of SNPs [15-17]. This extra cellular enzyme
shows excellent redox properties and it can act as an
electron shuttle in metal reduction [15,18]. It was evi-
dent that electron shuttles or other reducing agents (e.
g., hydroquinones) released by microorganisms are cap-
able of reducing ions to nanoparticles [19]. However,
the possible involvements of various macromolecules for
the reduction of silver ion into silver nanoparticles are
not reported yet. The identification of macromolecules
responsible for the SNPs biosynthesis would delineate
the possible mechanism of SNPs production in biologi-
cal model systems.
Here we report, for the first time, the involvement of
various proteins of oxido-reductive system and nuclear
histone protein of C. reinhardtii along with biochemical
substantiation in the biosynthesis and capping of SNPs.
The silver nanoparticles associated proteins were identi-
fied by mass spectrometry and the synthesized silver
nanoparticles were characterized by transmission elec-
tron microscope (TEM) for their shape and size distri-
bution. The current research report proposes the
possible molecular basis of the biosynthesis of SNPs and
the involvement of the oxidoreductive machinery in bio-
synthesis and stabilization of silver nanoparticles using
C. reinhardtii as model system.
Results
Biosynthesis of silver nanoparticles (SNPs)
In vitro synthesis of SNPs by C. reinhardtii cell free
extract was very slow (completed in 13 days) and synth-
esis kinetics was sigmoidal (Figure 1a). In vivo biosynth-
esis of SNPs was comparatively much faster than that of
in vitro condition (Figure 1b). The biosynthesis was
completed within 10 h of incubation in vivo (Figure 1b).
The reduction of Ag+ into Ag0 (SNPs) has appeared just
after the incubation and half of the SNPs were synthe-
sized within 30 min. The color of the culture solution
turned yellowish brown while the control algal culture
(without AgNO3) remained green (Figure 1b inset). The
synthesis of silver nanoparticles by C. reinhardtii live
cell showed hyperbolic synthesis kinetics (Figure 1b).
The maximum level of reduced silver (metal nanoparti-
cles) in C. reinhardtii (in vitro and in vivo) was in the
order of ~0.5-0.6 absorbance unit (Additional File 1). It
was found that the amount of SNPs has an upper limit,
which depends on the reducing capacity of the biologi-
cal extracts, AgNO3 concentration and incubation time
for the ease of reduction of the metal (Figure 1).
Morphological characterization of biosynthesized SNPs
Transmission electron microscopy (TEM) was used for
morphological characterization of in vitro and in vivo
synthesized SNPs. The shape of the biosynthesized SNPs
in both conditions were rounded/rectangular. However,
the size and universal size distribution were different for
in vitro and in vivo biosynthesized SNPs. In vivo bio-
synthesized SNPs were relatively larger than in vitro bio-
synthesized silver nanoparticles. The in vitro synthesized
nanoparticles were of size range 5 ± 1 to 15 ± 2 nm
(Figure 2a) whereas, the sizes range of in vivo biosynthe-
sized nanoparticles were 5 ± 1 to 35 ± 5 nm (Figure 2b).
The crystalline nature of these nanoparticles was further
confirmed by using TEM selected area distribution
study (SADS). The bright spot at regular interval con-
firms the highly crystalline nature of biosynthesized sil-
ver nanoparticles (Figure 2a &2b inset). The EDAX
(Energy-dispersive X-ray spectroscopy) analysis also con-
firms the presence of silver atoms in biosynthesized
nanoparticles (Figure 2a &2b inset). High-resolution
(HR) and Fourier transform images are the confirmatory
Figure 1 Kinetics of biosynthesis of silver nanoparticles (a)
Synthesis of nanoparticles in C. reinhardtii cell free extracts (in vitro)
system and (b) in vivo condition. The color of the C. reinhardtii cell
becomes yellowish brown after incubation with 1 mM AgNO3 in 5
hours (inset). (c) ICP-MS quantification of remaining Ag+ (in ppm)
after removal of in vivo biosynthesized SNPs.
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signature for crystalline nature of biosynthesized nano-
particles (Figure 2c and 2d).
Localization of in vivo synthesized SNPs in C. reinhardtii
cell
The black regions in the cytoplasm of C. reinhardtii
cells were due to the biosynthesis of silver nanoparticles,
which were gradually increased and finally filled the
complete cell (opaque cell, Figure 3a inset). Similar
patterns were also observed by scanning electron micro-
scope (SEM) analysis (Figure 3b). Normal C. reinhardtii
cells after incubation with AgNO3 show brighter spot
inside the cell due to synthesis of silver nanoparticles
(Additional File 2). The SNPs were densely localized in
periplasm and cytoplasm in the thin section (~ 60 nm)
of in vivo biosynthesized SNPs containing cells (Figure
3a and 3b and Additional File 3). On the closer evalua-
tion of the nanoparticles distribution within flagella of
Figure 2 Morphological characterization of the silver nanoparticles. (a) In vitro synthesis, diffraction pattern, and EDAX analysis was given in
inset (b) In vivo synthesis and its diffraction pattern (inset) (c) TEM high resolution Image (HR Image) of C. reinhardtii cell mediated synthesized
silver nanoparticles and (d) Magnified view of SNPs fringes and Fourier transform image in inset.
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C. reinhardtii cell, it was found that these SNPs were
also distributed inside and outside the flagella. The
numbers of nanoparticles were more towards the basal
body end than the distal end of the flagella (Figure 3c
and inset). The SNPs were highly localized at one side
of flagella root (basal body) and some part of the flagella
was distended due to the presence of excessive amount
of nanoparticles internally (Figure 3c and inset).
Protein depletion and its effect on rate of nanoparticles
synthesis, morphology and size
Proteins depletion experiments were performed to con-
firm the role of cellular proteins in the control of synthesis
rate of SNPs and their morphology. Cell free extract was
depleted on pre-equilibrated anion (DEAE-sepharose) and
cation exchange (CM-sepharose) chromatography col-
umns at pH 7.0 to maintain the functional and
Figure 3 Cellular localization of in vivo synthesized silver nanoparticles (a) TEM micrograph of thin section (~60 nm) and (b) SEM image of
1 mM AgNO3 incubated C. reinhardtii cell. (c) Silver nanoparticles localized on the flagellum.
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physiological condition of cellular proteins. The SDS-
PAGE and absorption scan of extract, DEAE and CM-
sepharose depleted fraction confirmed the various degree
of protein depletion (Additional File 4 and 5). The C. rein-
hardtii cell free extract showed multiple bands, few bands
in DEAE-sepharose depleted solution, and no detectable
band in CM-sepharose eluted fractions (Additional File 4).
The absorption peaks of these eluted fractions were
recorded at 280 nm and their intensity were higher for
extract, lower for DEAE-sepharose and lowest for CM-
sepharose eluted fractions (Additional File 5). The flow
through of each column and cell free extract was incu-
bated with Ag+ and the synthesis kinetics was measured
by absorption spectroscopy. The C. reinhardtii cell free
extract showed fast synthesis in comparison to that of ion
exchange chromatography depleted fractions (Figure 4a
and 4b). CM-sepharose eluted fraction showed lowest
synthesis among all the fractions (Figure 4a and 4b).
The effect of protein depletion on size and morphology
was also evaluated by the transmission electron micro-
scope (TEM). The size of nanoparticles synthesized by
extract was similar (5.0 ± 0.5 to ≥ 15 ± 2 nm) as
reported (Figure 2a and 5a). However, the size of nano-
particles synthesized by DEAE-sepharose flow through
(20 ± 4 nm) was larger in comparison to C. reinhardtii
cell free extract (Figure 5b). CM-sepharose flow through
fraction resulted 27 ± 5 nm silver nanoparticles synth-
esis under the similar conditions (Figure 5c).
Identification of SNPs bound proteins
Proteins associated on the in vitro and in vivo synthe-
sized SNPs were resolved on SDS-PAGE and the protein
bands were processed for MALDI-MS and MALDI-MS-
MS analysis (Figure 6a and 6b). The SNPs associated
proteins of in vitro, in vivo, DEAE and CM-sepharose
depleted fraction on SDS-PAGE were separately ana-
lyzed by MALDI MS-MS de novo sequencing. Nearly 18
silver nanoparticles bound proteins were identified from
various biosynthesis conditions. Most of the identified
SNPs associated proteins (in vitro and in vivo condition)
were the part of oxido-reductive machinery and showed
involvement in ATP synthesis, photosystem, and stress
response (Additional File 6). The MS-MS and mascot
search details of the SNPs associated bound proteins
were summarized in the Table 1. The freshly synthe-
sized and thoroughly washed (to remove proteins and
other bound surfactants) silver nanoparticles were incu-
bated with C. reinhardtii cell free extracts for 3.0 days
at room temperature. Separated and washed pre-synthe-
sized SNPs reveal different protein bands patterns to
that of biosynthesized SNPs on SDS-PAGE (Figure 6c).
Discussion
An important area of research in nanotechnology deals
with the controlled synthesis of environmentally benign
Figure 4 Total protein depletion experiments of C. reinhardtii
cell free extract (a) Synthesis kinetics of SNPs by C. reinhardtii cell
free extract (●), DEAE-sepharose (▼), CM-sepharose (○) depleted
flow through samples (b) The absorbance scans of C. reinhardtii cell
free extract, DEAE-sepharose and CM-sepharose depleted flow
through samples after silver nanoparticles synthesis.
Figure 5 Morphological characterization of protein depleted
synthesized SNPs (a) C. reinhardtii cell free extract, (b) DEAE-
sepharose and (c) CM-sepharose depleted flow through solution
synthesized SNPs.
Figure 6 Cellular protein profiling of biosynthesized SNPs.
Biosynthesized silver nanoparticles were gently washed (DW) and
equal amount of bound proteins were loaded on reducing SDS-
PAGE. The freshly synthesized silver nanoparticles (protein and
surfactant free) were incubated with C. reinhardtii cell free extracts
for three days. (a) Molecular weight marker (lane no 1), crude
extract (lane no 2) and supernatant after nanoparticles synthesis
(lane no 3). (b) Silver nanoparticles bound protein after 4 days (lane
no 4), 7 days (lane no 5) and 12 days (lane no 6) incubation at
reaction condition. (c) Protein binding on pre-synthesized silver
nanoparticles of increasing amount 40 μl (lane7), 70 μl (lane 8) and
100 μl (lane 9). The washed isolated nanoparticles were subjected
for SDS-PAGE analysis with different increasing volume.
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Table 1 MALDI-TOF-TOF of various SNPs associated proteins with matched sequences
No. Protein Name MW Coverage
(%)
Peptide Full proteins Sequence (Matched peptides bold underlined)
1 Histone H4 11.4 19.4 R.ISGLIYEETR.T; K.TFLENVIR.D; R.
DNIQGITKPAIR.R; K.RISGLIYEETR.T
MSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGV
KRISGLIYEETRTVLKTFLENVIRDSVTYTEHARRKTVTAMDVVY
ALKRQGRTLYGFGG
2 Carbonic anhydrase 41.6 42.8 K.QSPINVPQYQVLDGK.G; R.IVDV
LEMRPNDAADR.V
R.VTAVPTQFHFHSTSEHLLAGK.I; K.
IYPLELHIVHQVTEK.L; R.EGTFSNL
PAGTTIK.L
K.LGELLPSDR.D; R.ISFGQWNR.Y
K.ATVSGDHWDHGLNGENWEGK.D
R.DYVTYEGSLTTPPCSEGLLW
HVMTQPQR.I
CIYKFGTSPDSKATVSGDHWDHGLNGENWEGKDGAGNAWVCKTGR
KQSPINVPQYQVLDGKGSKIANGLQTQWSYPDLMSNGTSVQVINNGHT
IQVQWTYNYAGHATIAIPAMHNQTNRIVDVLEMRPNDAADRVTAVPTQ
FHFHSTSEHLLAGKIYPLELHIVHQVTEKLEACKGGCFSVTGILFQLDNGPDNEL
LEPIFANMPSREGTFSNLPAGTTIKLGELLPSDRDYVTYEGSLTTPPCSEGLLWHV
MTQPQRISFGQWNRYRLAVGLKECNSTETAADAGHHHHHRRLLHNHAHLEEVPAAT
SEPKHYFRRVMLAESANPDAYTCKAVAFGQNFRNPQYANGRTIKLARYH
3 Ferredoxin–NADP reductase 39.2 8.4 K.VLLLPADANAPLICVATGTGIAPFR.S AATKASTAVTTDMSKRTVPTKLEEGEMPLNTYSNKAPFKAKVRSVEKITGPKATGETCH
IIIETEGKIPFWEGQSYGVIPPGTKINSKGKEVPTARLYSIASSRYGDDGDGQTASLCV
RRAVYVDPETGKEDPAKKGLCSNFLCDATPGTEISMTGPTGKVLLLPADANAPLICV
ATGTGIAPFRSFWRRCFIENVPSYKFTGLFWLFMGVGNSDAKLYDEELQAIAKAYPGQ
FRLDYALSREQNNRKGGKMYIQDKVEEYADEIFDLLDNGAHMYFCGLKGMMP
GIQDMLERVAKEKGLNYEEWVEGLKHKNQWHVEVY
4 Superoxide dismutase 23.9 10.1 R.RPEYIAAWWNVVNWEQVAENYK.A MAQALPPLPYDYGSLEPHVDATTMNIHHTKHHQTYVNNLNAALDKFPELKDLGLV
DLNKAVGTDKLPKDVATVIRNNGGGHYNHSFFWKVMTNPSNTNGPNGDVKAAI
EASFGSVDEMKAKFNAAAAGRFGSGWAWLSVKPDGSLSIDSTPNQDNPLM
TALPDVAGGIPLLGLDVWEHAYYLKYQNRRPEYIAAWWNVVNWEQVAENYKA
AQAGTVPL
5 Sedoheptulose-1,7-bisphosphatase 41.7 21.8 R.ATFDNPAYER.L
K.AVSALDIPILVCDQR.T
R.TQICYGSIGEVR.R
R.EQVAAGMGIYGPR.T
R.LINFYLGEK.Y
R.ILFEVAPLALLIEK.A
RAARVQSRRTAVLTQAKIGDSLAEFLVEATPDPKLRHVMMSMAEATRTIAHKVRTASC
AGTACVNSFGDEQLAVDMVADKLLFEALKYSHVCKLACSEEVPEPVDMGGEGFCV
AFDPLDGSSSSDTNFAVGTIFGVWPGDKLTNITGREQVAAGMGIYGPRTVFCIALKD
APGCHEFLLMDDGKWMHVKETTHIGEGKMFAPGNLRATFDNPAYERLINFYLGEKY
TLRYTGGIVPDLFQIIVKEKGVFTNLTSPTTKAKLRILFEVAPLALLIEKAGGASSCDG
KAVSALDIPILVCDQRTQICYGSIGEVRRFEEYMYGTSPRFSEKVVA
6 ATP synthase subunit alpha 54.7 53.5 K.MVDFGIVFQVGDGIAR.I; K
.IAEIPVGEAYLGR.V
R.VVDGLARPVDGK.G; R.AIESPAPGIVAR.R
R.SVYEPLATGLVAVDAMIPVGR.G
K.TAIAVDTILNQK.G; K.ASSVA
QVLNTLKER.G
R.EAYPGDVFYLHSR.L
K.LKLELAQFAELEAFSQFASDLDQAT
QNQLAR.G
R.STLTFTPEAEGLVK.Q; K.QAINEYL
EEFKSQAK.A
R.TPEELSNLIKDLIEQYTPEVK.M; K.QAQA
YREMSLLLR.R; K.DLIEQ
YTPEVK.M; K.GVICVY
VAIGQK.A; K.QPQSSPLSV
EEQVASLYAGTN
GYLDKLEVSQVR.A
MAMRTPEELSNLIKDLIEQYTPEVKMVDFGIVFQVGDGIARIYGLEKAMSGELL
EFEDGTLGIALNLEANNVGAVLLGDGLKITEGSRVRCTGKIAEIPVGEAYLGR
VVDGLARPVDGKGAVQTKDSRAIESPAPGIVARRSVYEPLATGLVAV
DAMIPVGRGQRELIIGDRQTGKTAIAVDTILNQKGKGVICVYVAIGQKASSVA
QVLNTLKERGALDYTIIVMANANEPATLQYLAPYTGATLAEYFMYTGRPTLTIYDDLS
KQAQAYREMSLLLRRPPGREAYPGDVFYLHSRLLERAAKLNNALGEGSM
TALPIVETQEGDVSAYIPTNVISITDGQIFLAAGLFNSGLRPAINVGISVSRVG
SAAQPKAMKQVAGKLKLELAQFAELEAFSQFASDLDQATQNQLARGARLREIL
KQPQSSPLSVEEQVASLYAGTNGYLDKLEVSQVRAYLSGLRSYLANSYP
KYGEILRSTLTFTPEAEGLVKQAINEYLEEFKSQAKAA
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Table 1 MALDI-TOF-TOF of various SNPs associated proteins with matched sequences (Continued)
7 ATP synthase subunit beta 52.0 30.9 K.GQVPNIYNALTIR.A; R.TAPAFV
DLDTRLSIFETGIK.V
R.LSIFETGIK.V; K.VVDLLAPYR.R
K.VVDLLAPYRR.G; K.IGLFGGAGVGK.T
K.AHGGVSVFAGVGER.T; K.VALVYGQMNEPPGAR.
M
R.DVNKQDVLFFIDNIFR.F; R.FVQAGAEVSALLGR.M
R.TAPAFVDLDTR.L; R.VALTALTMAEYFR.D
R.DVNKQDVLFFIDNIFR.F; K.TVLIMELINNIAK.A
K.QDVLFFIDNIFR.F
MSDSIETKNMGRIVQIIGPVLDIVFAKGQVPNIYNALTIRAKNSAGTEMAVTCEVQ
QLLGDNCVRAVSMNPTEGLMRGMEVVDTGKPLSVPVGKVTLGRIFNVLGEPVDNM
GNVKVEETLPIHRTAPAFVDLDTRLSIFETGIKVVDLLAPYRRGGKIGLFGGAGV
GKTVLIMELINNIAKAHGGVSVFAGVGERTREGNDLYTEMKESGVIVEKNLSDS
KVALVYGQMNEPPGARMRVALTALTMAEYFRDVNKQDVLFFIDNIFR
FVQAGAEVSALLGRMPSAVGYQPTLATEMGGLQERITSTKDGSITSIQAVYVPA
DDLTDPAPATTFAHLDATTVLSRNLAAKGIYPAVDPLESTSTMLQPWILGEKHYDS
AQSVKKTLQRYKELQDIIAILGLDELSEEDRLIVARARKIERFLSQPFFVAEVFTGSPGKY
VSLAETIEGFGKIFAGELDDLPEQAFYLVGNITEAISKAASLK
8 ATP synthase gamma chain 38.7 15.0 K.VLYGVNQR.V; R.SLQEALASELAAR.M
R.AQEAVVNGRPFSENLVK.V
K.SVLLVVLTGDR.
MAAMLASKQGAFMGRSSFAPAPKGVASRGSLQVVAGLKEVRDRIASVKNTQKITDA
MKLVAAAKVRRAQEAVVNGRPFSENLVKVLYGVNQRVRQEDVDSPLCAVRPVKSV
LLVVLTGDRGLCGGYNNFIIKKTEARYRELTAMGVKVNLVCVGRKGAQYFARR
KQYNIVKSFSLGAAPSTKEAQGIADEIFASFIAQESDKVELVFTKFISLINSNPTIQT
LLPMTPMGELCDVDGKCVDAADDEIFKLTTKGGEFAVEREKTTIETEALDPSLIF
EQEPAQILDALLPLYMSSCLLRSLQEALASELAARMNAMNNASDNAKELKKG
LTVQYNKQRQAKITQELAEIVGGAAATSG
9 Oxygen evolving enhancer protein (OEE)
1
30.5 20.8 R.VAFLFTIK.Q
K.VTGLWYAQLK
K.VGSDGSAELKEDD
GIDYAATTVQLPGGER.V
LTFDEIQGLTYLQVKGSGIANTCPVLESGTTNLKELKAGSYKLENFCIEPTSFTVKEESQFKG
GETEFVKTKLMTRLTYTLDAMSGSFKVGSDGSAELKEDDGIDYAATTVQLPGGERVA
FLFTIKQFDGKGTLDGIKGDFLVPSYRGSSFLDPKGRGGSTGYDNAVALPARAD
AEELLKENVKITKALKGSAVFSVAKVDPVTGEIAGVFESIQPSDTDLGAKPPKDIKVTGL
WYAQLK
10 OEE2 25.8 25.5 K.WNPSKENDFPGVILR.
Y; K.ENDFPGVILR.Y
K.QAYSGETQSEGGF
APNR.V; K.TYYKYELLVR.S
AYGDSANVFGKVTNKSGFVPYAGDGFALLLPAKWNPSKENDFPGVILRYEDNFDA
VNNLVVIAQDTDKKAIADFGSQDKFLESVSYLLGKQAYSGETQSEGGFAPNRVSAASLL
DVSTTTDKKGKTYYKYELLVRSADGDEGGRHQLIGATVGSDNKLYIIKIQIGDKRWFKG
AKKEAMGAFDSFTVV
11 OEE-3 21.8 25.6 K.EFIQAVEDLDFALR.E; R.DRGFDLIYEAR.D
R.GFDLIYEAR.D;
R.DLDLPQNVR.E
LTPVDLFDDRSVRDRGFDLIYEARDLDLPQNVREGFTQARASLDETKKRVK
ESEARIDADLDVFIQKSYWTEAREQLRRQVGTLRFDLNTLASTKEKEAKKAALGLR
KEFIQAVEDLDFALREKDQASAAKKLEITKAKLDSVLAAVL
12 Ribulose bisphosphate carboxylase
(RuBisCO) (LC)
52.5 2.5 R.FLFVAEAIYK.A TKAGAGFKAGVKDYRLTYYTPDYVVRDTDILAAFRMTPQLGVPPEECGAAVAAESSTGT
WTTVWTDGLTSLDRYKGRCYDIEPVPGEDNQYIAYVAYPIDLFEEGSVTNMFTSIVGN
VFGFKALRALRLEDLRIPPAYVKTFVGPPHGIQVERDKLNKYGRGLLGCTIKPKLGLSA
KNYGRAVYECLRGGLDFTKDDENVNSQPFMRWRDRFLFVAEAIYKAQAETGEVKG
HYLNATAGTCEEMMKRAVCAKELGVPIIMHDYLTGGFTANTSLAIYCRDNGLLLHIHRA
MHAVIDRQRNHGIHFRVLAKALRMSGGDHLHSGTVVGKLEGEREVTLGFVDLMRDD
YVEKDRSRGIYFTQDWCSMPGVMPVASGGIHVWHMPALVEIFGDDACLQFGGGT
LGHPWGNAPGAAANRVALEACTQARNEGRDLAREGGDVIRSACKWSPELAA
ACEVWKEIKFEFDTIDKL
13 RuBisCO (SC) 20.6 39.3 K.AYVSNESAIR.F; R.FGSVSCLYYDNR.Y
K.AFPDAYVR.L; K.QVQIMGFLVQRPK.T
R.DFQPANKR.S
MMVWTPVNNKMFETFSYLPPLTDEQIAAQVDYIVANGWIPCLEFAEADKAYVSNESAIR
FGSVSCLYYDNRYWTMWKLPMFGCRDPMQVLREIVACTKAFPDAYVR
LVAFDNQKQVQIMGFLVQRPKTARDFQPANKRSV
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nontoxic nanoparticles of desired shape, sizes and
monodispersity. As a result, researchers in the field of
nanoparticles synthesis have turned to biological systems
to achieve desired qualities in synthesized nanoparticles.
Many organisms (both unicellular and multi-cellular)
are able to produce nanomaterials either intra- or extra-
cellularly, which are mediated by various oxidoreductive
molecules in the cells [16,20-27]. However, the molecu-
lar identity and role of these biomolecules in SNPs bio-
synthesis are yet to be reported. Our experiment shows
that C. reinhardtii cells (in vivo) mediated biosynthesis
of SNPs is faster than that of the in vitro (with cell free
extract) condition (Figure 1a and 1b). This is due to the
presence of different active biomolecules in the live cells
(in vivo) than the cell free extract. In vivo synthesized
nanoparticles are localized in cytoplasm, periplasm,
nucleus, pyrenoids, and also in the flagella assembly as
reported for the S. algae [7,28,29](Figure 3). Incubation
of the pre-synthesized silver nanoparticles in vitro does
not bind any protein while under similar condition the
biosynthesized SNPs does (Figure 6b and 6c). This con-
firms that these proteins only bind to SNPs during bio-
synthesis and it does not bind on the pre-synthesized
silver nanoparticles surface. These findings indicate that
the active proteins in cells play major role in the silver
nanoparticles biosynthesis.
Most of the C. reinhardtii cellular protein has been
depleted with CM- and DEAE-sepharose ion exchange
columns (Additional File 3). The proteins depleted frac-
tions show large size SNPs and slower synthesis (Figure
4). This is an indication of direct involvement of active
proteins in SNPs synthesis. It was observed that the size
of biosynthesized SNPs is inversely proportional to the
total protein content. This might be one of the reasons
for the synthesis of large-sized silver nanoparticles in
the CM and DEAE-sepharose depleted protein fractions
than cell free extracts (Figure 5). CM-sepharose protein
depleted fraction resulted bigger sized nanoparticles
than DEAE-sepharose protein depleted fractions (Figure
5). These biosynthesized metallic nanoparticles showed
size dependent collective oscillation of the conductance
electron at different wavelengths and their crystalline
nature (SADS, HRTEM, & Fourier image) is similar to
that of the chemically synthesized SNPs [16,30]. A vari-
ety of silver nanoparticles (size and shape) are synthe-
sized due to the amount and reactivity of proteinaceous
and non-proteinaceous oxidoreductive species and sur-
factants present in the biological system [21,26,31] (Fig-
ure 2).
Biologically synthesized silver nanoparticles (SNPs)
could have many applications in various fields but the
uncontrolled synthesis (with respect to size and shape of
SNPs) is major drawback for the commercial production
of SNPs using the biological system. The evaluation of
molecular mechanism of biosynthesis of SNPs is of
prime importance to understand biosynthesis process
and the development of methodology for controlling the
shape and size (uniform distribution) of SNPs. In this
report, the study is mainly focused to understand the
role of diverse algal cellular proteins in the biosynthesis
and capping of silver nanoparticles. Spectroscopic and
SDS-PAGE analysis indicate the accumulation of various
cellular proteins on C. reinhardtii mediated (in vivo and
in vitro) SNPs biosynthesis. Proteins involved in the
SNPs biosynthesis were identified by MALDI-MS-MS
using mascot platform. Most of these SNPs bound pro-
teins are from oxidoreductive machinery of Chlamydo-
monas cells. The major SNPs associated proteins are
identified as ATPase, sedoheptulose-1,7-bisphosphatase,
carbonic anhydrase, ferredoxin NADP+ reductase (FNR),
superoxide dismutase (SOD), oxygen evolving enhancer
protein (OEE), ribulose bisphosphate carboxylase and
nuclear histone (H4) (Table 1). Our experimental find-
ing of histone association with biosynthesized SNPs
indicates the role of C. reinhardtii histone (H4) in the
SNPs synthesis and capping. Carbonic anhydrase (CA),
Ferredoxin and Ferredoxin NADP+ reductase (FNR)
proteins are also found associated with synthesized
SNPs. The histone (H4) is well known for the reduction
of silver ammonia complex into ~20 nm SNPs and
binds SNPs with lysine rich AKRHRK domain [32-34].
This histone mediated SNPs synthesis is due to redox
reaction activity of this domain [35]. These proteins
might act together as redox centre for converting silver
ions into SNPs [36,37]. The involvement of NAD in
SNPs synthesis has also been predicted by Ahamad et
al. [38]. The binding of superoxide dismutase (SOD)
with biosynthesized SNPs suggest the involvement of
this protein in the reduction of Ag+ to SNPs. Recently,
it has been shown that superoxide (O2
–) is not only
involved in peroxide formation but is also able to reduce
Ag+ to Ag0. Further, this step might be sufficient for
nucleation step in SNPs synthesis and may modulate
rate of formation of SNPs [39]. Another SNPs associated
protein viz sedoheptulose-1, 7-bisphosphatase (SBPase)
might be involved in the capping of SNPs through its
free -SH group, which is generated by thioredoxin
mediated reduction [40,41]. Biosynthesized SNPs are
mostly localized in cup-shaped chloroplast of C. rein-
hardtii (Figure 3), a major organ for photosynthetic
machinery [42]. This machinery responds first to metal
stress by over expressing proteins like ATP synthase,
RuBP carboxylase and oxygen evolving enhancer protein
(OEE) proteins [43-45]. These enzymes are found asso-
ciated with C. reinhardtii mediated biosynthesized SNPs
(Table 1).
Based on the current findings and preliminary evi-
dence about the role of the cellular proteins for the
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biosynthesis of silver nanoparticles, it is accomplished
that the SNPs biosynthesis is governed by various cellu-
lar proteins present in the system. The other small bio-
molecules may have potential to act as various
oxidation-reduction systems for SNPs biosynthesis either
separately or as supplementary to these proteins part-
ners. It would be interesting to delineate the role of
identified protein molecule(s) in the control of size and/
or shape of the biosynthesized nanoparticles.
Conclusions
Most of the eukaryotic organisms are reported to have
potential to synthesize silver nanoparticles of different
shape/size and synthetic rate depending on their protei-
naceous and non- proteinaceous biochemical oxidore-
ductive species. Our work confirms the SNPs
biosynthesis potential of C. reinhardtii as unicellular
model system. Further study to evaluate the molecular
mechanism of SNPs biosynthesis, we have found various
cellular proteins viz histone (H4), CA, FNR, SOD,
SBPase, ATP synthase, RuBP carboxylase, and OEE
associated with biosynthesized SNPs. However, these
proteins are not associated with the pre-synthesized sil-
ver nanoparticles. The alterations in size and biosynth-
esis rate of SNPs by proteins depleted fractions confirm
that these proteins have direct control on C. reinhardtii
mediated biosynthesis of SNPs. This is the first report of
elucidation of molecular machinery and the role of oxi-
doreductive cellular proteins in the biosynthesis of silver
nanoparticles.
Methods
Culture of the C. reinhardtii
Chlamydomonas strain CC-124 (green algae) was pro-
cured from Chlamydomonas centre, Duke University, U.
S.A. The culture was maintained on agar plate by adding
1.5% agar in TAP media supplemented with Hutner’s
trace element solution. Culture was grown in TAP
media under optimum light conditions i.e, 2300 lux.
Cells were collected by centrifugation at 3500 rpm for
5.0 min at room temperature and washed properly with
distilled water (DW).
Preparation of C. reinhardtii cell free extract for
nanoparticle biosynthesis
Typically, 2 g (wet weight) biomass of C. reinhardtii was
suspended in 20 ml of double distilled sterile water for
2 h at 27°C in an Erlenmeyer flask with gentle agitation
followed by vortexing with glass beads. To avoid heating
due to the vigorous mixing, the cells were agitated for 1
min, followed by a 30 s cooling period between agitation
cycles. Finally, the cells were broken by intermittent
sonication (2 second on and 10 second off pulse) at 4°C
in ice for 10 min at 40% amplitude. The cell suspension
was examined microscopically until most of the cells
were broken. Cell free filtrate was obtained by centrifu-
gation of the C. reinhardtii at 10000 rpm for 10 min at
4°C. This solution (10% wet w/v) was used for the
further experiments.
Silver nanoparticles synthesis
In vitro
The SNPs synthesis reaction was carried out by incubat-
ing 10% (v/v) of cell free extract with 1.0 mmol L-1 aqu-
eous AgNO3 (double distilled water) solution for 15
days at room temperature in dark. The change in color
of the whole solution was an indication of the synthesis
of SNPs. The solution was centrifuged at 12000 rpm for
20 min to separate the SNPs. These SNPs were washed
five times with double distilled water and separated
from reaction mixture along with the associated
proteins.
In vivo
The optimally grown culture (100 ml) was centrifuged
(3000 rpm) for 5 min in sterile condition, washed three
times to remove the culture medium and resuspended
in 50 ml autoclaved water. The stock solution of
AgNO3 (autoclaved) in water was added to make the
final 1 mM AgNO3 solution. One ml reaction solution
was harvested, sonicated, filtered to remove cell debris,
centrifuged, washed and resuspended in 200 μl of dis-
tilled water at different time intervals (Figure 1) to study
the kinetics of SNPs synthesis. The absorbance scan was
taken for the entire sample and the biosynthesized SNPs
were characterized electron microscopically/elemental/
crystallinity for their morphology using TEM, EDAX
and HRTEM image respectively.
Spectroscopic and kinetic characterization of silver
nanoparticles
The reduction of silver ions was monitored by measur-
ing absorbance scan at 250-700 nm at selected time
intervals with UV-VIS spectrophotometer (Nano Drop)
(Figure 1). Change in color was observed in the silver
nitrate solution incubated with the C. reinhardtii cell
free extract. The silver nanoparticles dispersed in water
were kept at room temperature (37°C) and the absorp-
tion at 470 nm was measured continuously to determine
their stability.
The conversion of AgNO3 into SNPs were determined
indirectly on Inductively Coupled Plasma-Mass Spectro-
metry (ICP-MS) by measuring the remaining Ag+ con-
centration in supernatant after removal of
biosynthesized SNPs (by centrifugation) at various time
interval (0, 0.5, 1, ...10 h). Briefly, 4 ml of the SNPs free
supernatant was dried at 105°C for 3 h. After addition
of 4 ml of concentrated nitric acid and 0.5 ml of con-
centrated hydrochloric acid, the samples were digested
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by using a microwave power progressively increasing up
to 400 W for 40 min. After cooling, the solutions were
accurately diluted to 50 ml with water. One replicate
per digestion method was done for each sample and
they were analyzed directly by ICP-MS.
SDS-PAGE gel analysis of SNPs associated proteins
Thoroughly washed C. reinhardtii cellular proteins asso-
ciated with SNPs were heated at 95°C for 5 min to dissoci-
ate the cellular proteins from SNPs. The SNPs were
separated from the solution by centrifugation at 14000
rpm. The protein content of this solution was quantified by
Bradford assay. 100 μg (as determined using the Bradford
assay) of the soluble proteins were heated at 95°C for 5
min in 4% b-mercaptoethanol and 2% SDS. Proteins asso-
ciated with the SNPs were resolved on 12% SDS-PAGE.
Sample preparation for proteomics
Protocol for sample preparation for proteomics analysis
of SNPs associated proteins was adopted from published
papers [46,47]. Briefly, protein bands on SDS-PAGE were
excised, de-stained, washed with water and dehydrated
with acetonitrile (ACN). Proteins were reduced with 10
mM DTT (dithiothreitol) solution in trypsin digestion
buffer at 60°C for 30 min. After cooling at room tempera-
ture, gels were dehydrated with ACN. The proteins were
alkylated with 50 mM iodoacetamide solution in trypsin
digestion buffer in dark as per manufacturer’s instruction.
After washing with ACN, gel samples were dried in
speedvac. Gel pieces were rehydrated with trypsin rehy-
dration solution containing 50 ng of trypsin and incu-
bated at 37°C overnight for in gel digestion of protein.
Peptides were recovered with Pep-extract buffer (sup-
plied with kit), lyophilized, and reconstituted in 10 μl of
50% ACN and 0.1% trifluoroacetic acid (TFA).
MALDI MS-MS analysis of SNPs bound proteins
MALDI experiments were performed on pre-calibrated
ABI 4800 plus MALDI-TOF-TOF analyzer (Applied
Biosystem) at department of Biochemistry, Delhi Univer-
sity South Campus, New Delhi, India. Reconstituted
peptides were spotted on 384 well LC MALDI stainless
steel plate. For MS analysis, spots were illuminated with
laser intensity of 3500 and total 1200 spectra were
recorded [48,49]. For MS-MS analysis, 25 precursors/
peptides were selected from each spot and depending
upon their abundance, each precursor was fragmented
in the collision cell. Peptide fragmented with 4300 laser
intensity and 2500 shots were accumulated for proces-
sing of data [50,51].
The resultant PMF and peptide fragments were
searched against swissprot database on MASCOT search
engine http://www.matrixscience.com. The search of
database was focused for Virdiplantae group containing
green algae and land plant genome database. The mono-
isotopic peptide tolerance was kept at ± 100 ppm with
MS/MS tolerance of ± 0.6 Da.
Protein depletion experiment
The protein depletion experiment was carried out to
confirm the role of various proteins in the biosynthesis
of silver nanoparticles. The C. reinhardtii cell free
extract (5 ml) was passed through pre-equilibrated CM-
sepharose and DEAE-sepharose ion exchange chromato-
graphic column at pH 7.0. The flow through of each
column was used for the biosynthesis of silver nanopar-
ticles and to characterize their synthesis kinetics. Mor-
phological comparisons of the biosynthesized SNPs were
characterized by using TEM.
Protein binding assay
Protein binding assay was performed to confirm the
involvement of various proteins either in the synthesis
or capping or both. For this purpose, freshly synthesized
SNPs (without any protein capping) were incubated
with C. reinhardtii cell free extract for three days in
standard conditions. These nanoparticles were separated,
gently washed and heated with 0.2% SDS to dissolve all
the bound protein on nanoparticles. The supernatant
after the SDS treatment was resolved on the SDS PAGE.
Electron microscopic characterization of SNPs
SEM imaging
Biosynthesis of silver nanoparticles in vivo was character-
ized by scanning electron microscope (S-3400 N, Hitachi,
Japan). The AgNO3 incubated C. reinhardtii cultures at
different time (0, 1, 5, and 8 h) were mounted on an alu-
minum stub using double sided carbon tape. The comple-
tely dried sample was coated with gold by sputter coating
unit (E1010 ion sputter Hitachi, Japan) and image was
captured on SEM mode at desired magnification.
TEM, diffraction and EDAX characterization of nanoparticles
The morphology and grain size of the C. reinhardtii bio-
synthesized silver nanoparticles were observed by high-
resolution transmission electron microscopy using FEI
G-20 model operated at 200 kV. The crystallinity of the
nanoparticles was determined using selected area elec-
tron diffraction (SAED) coupled with TEM. Elemental
analysis of the nanoparticles was carried out using a
scanning transmission electron microscope (STEM)
equipped with an energy dispersive X-ray (EDX) spec-
trometer (EDAX). Briefly, the washed biosynthesized
SNPs were directly spread on grid and dried before
TEM imaging. However, the cells were fixed with glutar-
aldehyde, OsO4 and embedded in resins after serial
alcohol dehydration for exploring the cellular localiza-
tion of in vivo synthesized SNPs. The ultrathin sections
(~60 nm) of the cells were used for the TEM imaging.
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Additional material
Additional file 1: UV visible scan (a) in vitro and (b) in vivo system
SNPs biosynthesis. This file shows the absorbance scan at various time
(given along with figure) in vitro and in vivo conditions.
Additional file 2: Cellular localization of in vivo synthesized silver
nanoparticles. (a) TEM micrograph SNPs synthesizing cell at different
time and (b) SEM image of 1 mM AgNO3 incubated C. reinhardtii cell at
different time period (given in the right corner of each image).
Additional file 3: Cellular localization of silver nanoparticles inside
the cell. Various TEM micrograph of thin section (~60 nm) of in vivo
biosynthesized SNPs containing cells for better conspicuousness.
Additional file 4: SDS-PAGE of equal volume (50 and 100 μl) of C.
reinhardtii depleted proteins. Cell free extract (lane 1-2), DEAE-
Spharose depleted flow through (lane 3-4), DEAE 0.5 M salt wash (lane 5-
6), CM-sepharose depleted flow through (lane 7-8), and CM-sepharose
0.5 M salt wash (lane 9-10).
Additional file 5: Absorbance scans of protein depleted fractions.
The absorbance scans of C. reinhardtii cell free extract, DEAE-Spharose,
CM-sepharose depleted flow through samples before AgNO3 incubation.
Additional file 6: PMF (upper panel) and MS-MS (lower panel)
spectra of SNPs associated various identified proteins. (a) ATP
synthase subunit alpha, chloroplastic OS = Chlamydomonas reinhardtii (b)
ATP synthase subunit beta, chloroplastic (c) Carbonic anhydrase (d)
Sedoheptulose-1,7-bisphosphatase (e) Ferredoxin, chloroplastic (f)
Oxygen-evolving enhancer protein 1, chloroplastic (g) Oxygen-evolving
enhancer protein 2, chloroplastic (h) Oxygen-evolving enhancer protein 3
(i) Histone H4. de novo sequence of the peptides was given along with
each MS-MS spectra in red.
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